SCHEMBL17969083

SCHEMBL17969083

CC(Oc1cc(-c2nn[nH]c2C#N)cc(C(F)(F)F)c1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 1/20 0.38
▸ TACR1 P25103 4/20 0.35
▸ SLC6A2 P23975 3/20 0.34
▸ SLC6A4 P31645 3/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ NOS2 P35228 2/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.33
▸ AR P10275 1/20 0.33
▸ ATP1A1 P05023 1/20 0.32
▸ ATP1B1 P05026 1/20 0.32
▸ ATP1A3 P13637 1/20 0.32
▸ ATP1B2 P14415 1/20 0.32
▸ ATP1A2 P50993 1/20 0.32
▸ ATP1B3 P54709 1/20 0.32
▸ FXYD2 P54710 1/20 0.32
▸ ATP1A4 Q13733 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA2B P29275 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18004917 0.87 IKBKE (0.36) FFAR4NPSR1ARKDM5A
SCHEMBL16398927 0.87 FFAR4 (0.38) FFAR4SLC6A2SLC6A4KDM4EHTT
SCHEMBL18003790 0.86 SLC6A4 (0.40) SLC6A2SLC6A4CYP2D6NOS2KDM4E
SCHEMBL17969107 0.83 CYP1A2 (0.40) TACR1SLC6A2SLC6A4NPSR1ADORA2A
SCHEMBL18004313 0.80 MAOB (0.39) CTSS
SCHEMBL18004918 0.80 FFAR4 (0.32) FFAR4ARCTSSCTSK
SCHEMBL18003796 0.80 SCN9A (0.37) FFAR4KDM4EHTTSMN1; SMN2KDM5A
SCHEMBL18004227 0.80 KDM5A (0.39) FFAR4KDM5ACTSSCTSK
SCHEMBL18004339 0.79 RXRA (0.39) TACR1SLC6A2SLC6A4ADORA2AADORA1
SCHEMBL18004919 0.79 FFAR4 (0.38) FFAR4CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4570313-A2 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2025-06-18 — — EP disclosed
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 — — EP disclosed
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 — — EP disclosed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 — — US disclosed
US-10626095-B2 Cyanotriazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-04-21 — — US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 — — US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 — — US disclosed
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 — — US disclosed
CN-105408325-A Cyanotriazole compounds OTSUKA PHARMA CO LTD 2016-03-16 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626095-B2 Cyanotriazole compounds CS, PC, ACAT1 FFAR4 1992/4885TACR1 2704/4885SLC6A2 2400/4885
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS CS, PC, ACAT1 FFAR4 1992/4885TACR1 2704/4885SLC6A2 2400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback